![](/img/cover-not-exists.png)
Letter: new thresholds need to be defined when using point of care assays to monitor infliximab trough levels in IBD patients
Dutzer, D., Nasser, Y., Berger, A. E., Roblin, X., Paul, S.Volume:
47
Language:
english
Journal:
Alimentary Pharmacology & Therapeutics
DOI:
10.1111/apt.14645
Date:
June, 2018
File:
PDF, 414 KB
english, 2018